<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04769726</url>
  </required_header>
  <id_info>
    <org_study_id>NDOC/11/2017</org_study_id>
    <nct_id>NCT04769726</nct_id>
  </id_info>
  <brief_title>Pre-meal Load of Raw Almonds and Postprandial Hyperglycemia</brief_title>
  <official_title>Evaluation of Pre-meal Load of Raw Almonds on Postprandial Hyperglycemia and Other Metabolic Responses in Asian Indians With Prediabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diabetes Foundation, India</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Diabetes Obesity and Cholesterol Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Diabetes Foundation, India</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A few studies show the effect of almonds on postprandial hyperglycemia (PPHG); high blood&#xD;
      glucose after meals. In our previous study on intervention with almonds, we observed a&#xD;
      significant decrease in HbA1C and a small decrease in fasting blood glucose indicating a&#xD;
      possible effect of almonds on PPHG. Studies have shown that a preload of a food article that&#xD;
      is high in protein, mono-unsaturated fatty acids, fiber, and low in carbohydrates, such as&#xD;
      almonds could be helpful in stimulating insulin secretion and help improve postprandial&#xD;
      hyperglycemia. The proposed study shall be undertaken to assess the effect of almond&#xD;
      supplementation on postprandial hyperglycemia in Asian Indians with prediabetes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Acute Phase Study: Randomized controlled cross over study design Number of arms: 2,&#xD;
           almond and control, n=60 needed (30 in each arm) Subjects randomized to almonds arm are&#xD;
           given a preload of 20 g of almonds 30 minutes prior to ingestion of 75 g of glucose,&#xD;
           while those in the control arm do not have any food/almonds before OGTT. Blood samples&#xD;
           are collected at (minutes): -30, 30, 0, 30, 60, 90 and 120. Cross over of these subjects&#xD;
           is done and OGTT repeated in a similar manner. Assessment of blood glucose, serum&#xD;
           insulin, glucagon, C-peptide, serum triglycerides, free fatty acids, DPP-IV, and GLP1&#xD;
           levels are done at these time points.&#xD;
&#xD;
        -  Sub-Acute Study:&#xD;
&#xD;
      Three-day almond preload study monitored with CGMS, n=60 needed. All study participants&#xD;
      undergoing OGTT are further studied with CGMS for three days each and then crossed over.&#xD;
      Those in almonds arm continue to receive preload of almonds for three days and then studied&#xD;
      without almond preload after cross over. A washout period of 7 days separates cross-over&#xD;
      period.&#xD;
&#xD;
      o Chronic Phase Study: Ninety days almond preload study monitored with self-monitoring of&#xD;
      blood glucose; n=60 needed.&#xD;
&#xD;
      This is a randomized controlled parallel-arm study to evaluate the long-term effect of&#xD;
      preload of almonds on hyperglycemia. Subjects fulfilling the inclusion/exclusion criteria are&#xD;
      randomized to either the control arm or the almond arm.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 16, 2017</start_date>
  <completion_date type="Actual">February 20, 2021</completion_date>
  <primary_completion_date type="Actual">February 20, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postprandial hyperglycemia</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Intervention</condition>
  <arm_group>
    <arm_group_label>treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>almonds</intervention_name>
    <description>almond intervention (25% of total energy) for 3 months</description>
    <arm_group_label>treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Age 18 to 60 years Prediabetes as diagnosed on oral glucose tolerance test (OGTT): Fasting&#xD;
        blood glucose ≥100mg/dl and &lt;126 mg/dl and 2-h plasma glucose ≥140mg/dl and &lt;200mg/dl&#xD;
        (after ingestion of 75 gram anhydrous oral glucose) or 2-h plasma glucose ≥140mg/dl and&#xD;
        &lt;200mg/dl alone.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Acute infections and advanced end-organ damage History of hepatitis or pancreatitis,&#xD;
        abnormal liver and renal functions Recent (&lt;3 months) changes in weight (≥5%) and/or weight&#xD;
        changing medications Any known allergy to nuts uncontrolled hypertension or hypothyroidism&#xD;
        suffering from acute infection or any debilitating disease or with renal failure&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Anoop misra</name>
      <address>
        <city>New Delhi</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 22, 2021</study_first_submitted>
  <study_first_submitted_qc>February 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 24, 2021</study_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>almonds</keyword>
  <keyword>Asian Indians</keyword>
  <keyword>Prediabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

